OREANDA-NEWS. Imaginatik plc (AIM: IMTK.L), the world's first full service innovation provider offering a range of technology products and consultancy services, is pleased to announce that, following the trading update on 11 February 2015, it has signed two further contracts, one with a leading US based biotech company and the other with a leading Canadian media service, both of which have an initial one year term.

 Under the terms of the contract with the US biotech company, Imaginatik will provide its consulting expertise and technology platforms in order to support the customer in initiating its own innovation programme. Imaginatik will help catalyse, develop and incorporate innovation capabilities across the business, enabling the customer to adjust efficiently to its evolving and dynamic marketplace.

 Additionally Imaginatik will provide the technology platform and consulting support to the Canadian media service as they look to upgrade from a previous platform provider as they seek to expand and enhance their innovation strategy.

 Matt Cooper, Non-Executive Chairman, commented: "I am delighted to announce that we are able to further increase our customer base and both these new contracts demonstrate the high quality offering and added value that we can deliver to our customers. We look forward to working with and expanding our reach across the biotech industry. In addition, we will support the Canadian media service in committing to Imaginatik's full platform and through this we will help catalyse and build a sustainable innovation competency within the organisation to capture new sources of value."

"These additional contract wins demonstrate that our approach and expertise continue to offer significant benefits to our customers, and enable them to develop and enhance their innovation competencies through capturing new sources of value regarding business and growth strategies."